Prepulse inhibition (PPI) and attention were impaired, which may cause psychotic symptoms and (or) hinder the cognitive functions in schizophrenia. However, due to the measurement methods of PPI, findings about the relationship between PPI and clinical symptoms, cognitive performances have been equivocal.
Seventy-five schizophrenia patients (SZ) and 50 healthy controls (HC) were assessed in a modified acoustic PPI paradigm, named perceived spatial separation-induced PPI (PSS-PPI), compared to perceived spatial co-location PPI (PSC-PPI) with inter-stimulus interval (ISI) of 120 ms. Repeatable Battery for the Assessment of Neuropsychological Status and the Stroop Color-Word Test were administered to all subjects.
Significant decrease in the modified PPI was found in the patients as compared to the controls, and effect sizes (Cohen’d) for patients vs. HCs % PPI levels achieved a significant level (PSC-PPI d = 0.84, PSS-PPI d = 1.27). A logistic regression model based on PSS-PPI significantly represented the diagnostic grouping (χ2 = 29.3; p < 0 .001), with 85.2% area under ROC curve in predicting group membership.
In addition, patients exhibited deficits in neurocognition. Among patients of “non-remission”, after controlling for gender, age, education, duration, recurrence times, onset age, cigarettes per day and chlorpromazine equivalent dosage, PSS-PPI levels were associated with positive and negative symptoms, PANSS total and thought disorder (P1, P6, P7, N5, N7, G9). In multiple linear regression analyses, male and higher attention scores contributed to better PSC-PPI and PSS-PPI in controls group, while larger amount of smoke and longer word-color interfere time contributed to poor PSS-PPI. In patients’ group, higher education and attention scores contributed to better PSS-PPI, while repeated relapse contributed to poor PSS-PPI.
The acoustic perceived spatial separation-induced PPIs may bring to light the psychopathological symptoms, especially for thought disorder, and the mechanism(s) of the novel PPI paradigm was associated with attention function.
Adler LE, Pachtman E, Franks R, Pecevich M, Waldo M, Freedman R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry. 1982;17(6):639-654.
Swerdlow NR, Geyer MA, Blumenthal TD, Hartman PL. Effects of discrete acoustic prestimuli on perceived intensity and behavioral responses to startling acoustic and tactile stimuli. Psychobiology. 1999;27(4):547–56.
Braff DL, Swerdlow NR, Geyer MA. Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. American Journal of Psychiatry. 1999;156(4):596-602.
Kumari V, Soni W, Sharma T. Normalization of information processing deficits in schizophrenia with clozapine. Am J Psychiatr. 1999;156(7):1046–51. PubMed
Oliveras I, Rio-Alamos C, Canete T, Blazquez G, Martinez-Membrives E, Giorgi O, Corda MG, Tobena A, Fernandez-Teruel A. Prepulse inhibition predicts spatial working memory performance in the inbred Roman high- and low-avoidance rats and in genetically heterogeneous NIH-HS rats: relevance for studying pre-attentive and cognitive anomalies in schizophrenia. Front Behav Neurosci. 2015;9:213. CrossRefPubMedPubMedCentral
He Y, Zhang M. The positive and negative syndrome scale (PANSS) and its application. J Clin Psychiatry. 1997;7(6):353–5.
Wang J, Li C, Cheng Y, Yi Z, Long B, Wang J. Reliability and validity of repeatable battery for the assessment of neuropsychological status (RBANS) in schizophrenic patients: a preliminary study. Shanghai Arch Psychiat. 2009;21:265–8.
Wang X, Ren Y, He J, Zhou D. Evaluation of Cognitive Functions and Its Corelation with Psychiatric Symptoms in Patients with Schizophrenia [J]. J Capital Med Univ. 2008;29(4):423–7.
Team RC: R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2013. In .: ISBN 3-900051-07-0; 2014.
- Deficits of perceived spatial separation induced prepulse inhibition in patients with schizophrenia: relationships to symptoms and neurocognition
- BioMed Central